Good discussion. I agree Craig Cooper has made a mess of the Mobovoi launch by advertising prizes 6 months ago and using the word imminent which has lost its meaning.
I dont think the pulse product will have any problems getting FDA approval as it is based on the already FDA approved SphygmoCor technology. I think this in itself would give a 50 million market cap as i think it would be disruptive in the unique readings it gives compared to other products currently on market. I know Omron is in other spaces but has a 20 billion market cap and is the Global No.1 brand in digital blood pressure monitors with over 200 million BPM’s sold worldwide. Have to dig deeper but how would the pulse compare. Would CDX have the best product on market?
I like Lex and Stormers negative comments as they make me think deeper about my investment here. I dont agree that the Mobovoi watch was ever supposed to be FDA approved as the timelines they initially talked about could never have been executed waiting on FDA approval. As from the SEPT 2020 announcement
Initial phase of the partnership agreement is a 6 month limited market release targeted for Q1 2021. Why such a long time for release could possibly been technical issues but does not matter as is launching latest i
Add to My Watchlist
What is My Watchlist?
